Provided by Tiger Fintech (Singapore) Pte. Ltd.

ESSA Pharma

1.72
+0.01000.58%
Volume:189.80K
Turnover:325.64K
Market Cap:76.35M
PE:-2.45
High:1.75
Open:1.72
Low:1.70
Close:1.71
Loading ...
Aug 20, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Aug 17, 2021

Statement Of Changes In Beneficial Ownership

3 - Initial statement of beneficial ownership of securities
May 06, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 05, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Mar 31, 2021

Major Issues Report

8-K - Current report
Mar 02, 2021

Major Issues Report

8-K - Current report
Feb 22, 2021

Major Issues Report

8-K - Current report
Feb 16, 2021

Major Issues Report

8-K - Current report
Feb 16, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 12, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 12, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 12, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 12, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2021

Major Issues Report

8-K - Current report
Feb 11, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Dec 23, 2020

Correspondence

CORRESP [Cover] - Correspondence
Dec 23, 2020

Correspondence

CORRESP [Cover] - Correspondence
Dec 23, 2020

Correspondence

CORRESP [Cover] - Correspondence